Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513485 | SCV000608631 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4 |
Labcorp Genetics |
RCV001424367 | SCV001626964 | likely benign | Long QT syndrome | 2024-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420292 | SCV002677351 | likely benign | Cardiovascular phenotype | 2020-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |